BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7272366)

  • 1. [Isolation and some properties of Hageman factor and its active fragment from human blood].
    Krizhevskaia IuV; Iarovaia GA; Dotsenko VL; Khvatov VB
    Biokhimiia; 1981 Aug; 46(8):1510-8. PubMed ID: 7272366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-step preparation of Hageman factor fragment concentrate.
    Simonianová E
    Biomed Chromatogr; 1992; 6(4):194-5. PubMed ID: 1643388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation, purification, and properties of factor XII and its active fragment (beta-XIIa)].
    Blokhina TB; Neshkova EA; Iarovaia GA
    Vopr Med Khim; 2002; 48(6):603-10. PubMed ID: 12698561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activation of prekallikrein from human blood serum by different activators].
    Iarovaia GA; Dotsenko VL; Krizhevskaia IuV; Morozova NA; Orekhovich VN
    Biokhimiia; 1979 Jul; 44(7):1279-85. PubMed ID: 497275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of the Hageman factor fragment from human serum albumin by chromatography on blue sepharose CL-6B.
    Simonianová E; Hrkal Z
    Biomed Chromatogr; 1990 Jul; 4(4):152-3. PubMed ID: 2207375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylactic release of a prekallikrein activator from human lung in vitro.
    Meier HL; Kaplan AP; Lichtenstein LM; Revak S; Cochrane CG; Newball HH
    J Clin Invest; 1983 Aug; 72(2):574-81. PubMed ID: 6192147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of beta-XIIa (Hageman factor fragment) from human plasma.
    Tankersley DL; Alving BM; Finlayson JS
    Thromb Res; 1982 Feb; 25(4):307-17. PubMed ID: 6978550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of Hageman factor (factor XII) of the guinea pig to prekallikrein activator and inhibition of the formed kallikrein by a natural plasma inhibitor.
    Takeuchi Y; Movat HZ
    Eur J Immunol; 1972 Aug; 2(4):345-9. PubMed ID: 4538864
    [No Abstract]   [Full Text] [Related]  

  • 10. The interaction of Hageman factor and immune complexes.
    Cochrane CG; Wuepper KD; Aiken BS; Revak SD; Spiegelberg HL
    J Clin Invest; 1972 Oct; 51(10):2736-45. PubMed ID: 5056666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
    Cochrane CG; Wuepper KD
    J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
    Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
    J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor.
    Takahashi H; Nagasawa S; Suzuki T
    J Biochem; 1980 Jan; 87(1):23-34. PubMed ID: 6766924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chromatographic method of analyzing Hageman factor (blood coagulation factor XII) in human serum].
    Krizhevskaia IuV; Dotsenko VL; Iarovaia GA
    Vopr Med Khim; 1982; 28(2):128-32. PubMed ID: 7080474
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural changes accompanying enzymatic activation of human Hageman factor.
    Revak SD; Cochrane CG; Johnston AR; Hugli TE
    J Clin Invest; 1974 Sep; 54(3):619-27. PubMed ID: 4277669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Hageman factor by proteases released during antigen challenge of human lung.
    Newball HH; Meier HL; Kaplan AP; Revak SD; Cochrane CG; Lichtenstein LM
    Trans Assoc Am Physicians; 1981; 94():126-33. PubMed ID: 7046190
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
    van der Kamp KW; van Oeveren W
    J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Hageman factor and its fragments.
    Silverberg M; Kaplan AP
    Methods Enzymol; 1988; 163():68-80. PubMed ID: 3237092
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of prekallikrein activator from guinea pig serum or plasma adsorbed to immune precipitates or celite: possible relationship to Hageman factor.
    Treloar MP; Pyle H; Ozge-Anwar AH; Takeuchi Y; Movat HZ
    Eur J Immunol; 1972 Aug; 2(4):338-45. PubMed ID: 5083514
    [No Abstract]   [Full Text] [Related]  

  • 20. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
    Mandle R; Kaplan AP
    J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.